Rescuing Neurodegeneration with TREM2 Agonism: a Small Molecule Approach Targeting Neuroimmunology in Alzheimer’s Disease
Time: 4:30 pm
day: Conference Day One
Details:
- Exploring a small molecule approach to enhance microglial function with TREM2 modulation, to improve neuroprotection
- Navigating implications on back translation to the clinic
- Outlining early biomarker data (GFAP, NFL,…) and implementation approach to further determine patient benefit
- Exploring patient stratification rationale to identify patients most likely to benefit from treatment
